<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The hematologic, cytomorphologic, and cytogenetic features of 50 cases of <z:hpo ids='HP_0001909'>leukemia</z:hpo> cutis (LC), occurring in 40 patients, are presented </plain></SENT>
<SENT sid="1" pm="."><plain>The patients' ages ranged from 19 to 75 years (mean, 42 years) </plain></SENT>
<SENT sid="2" pm="."><plain>The primary hematologic diagnoses in these patients included <z:hpo ids='HP_0011009'>acute</z:hpo> non-lymphoblastic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (ANLL), 13 patients; <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), 19 patients; <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo>, 3 patients; <z:hpo ids='HP_0011010'>chronic</z:hpo> granulocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo>, 3 patients; and <z:hpo ids='HP_0001901'>polycythemia</z:hpo> vera, 1 patient </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0001909'>Leukemia</z:hpo> cutis developed in one patient without any known prior or subsequent <z:e sem="disease" ids="C1521860" disease_type="Disease or Syndrome" abbrv="">hematologic disorder</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The 13 cases of ANLL included French-American-British types M1 (1 case), M2 (5 cases), M3 (1 case), M4 (5 cases), and M5 (1 case) </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0001909'>Leukemia</z:hpo> cutis preceded blood and/or bone marrow manifestations of <z:hpo ids='HP_0001909'>leukemia</z:hpo> in nine patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and one with ANLL </plain></SENT>
<SENT sid="6" pm="."><plain>The interval from skin biopsy to systemic <z:hpo ids='HP_0001909'>leukemia</z:hpo> ranged from 3 weeks to 20 months (mean, 6 months) </plain></SENT>
<SENT sid="7" pm="."><plain>In seven patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and three patients with ANLL, LC occurred concomitantly with leukemic transformation </plain></SENT>
<SENT sid="8" pm="."><plain>Only two patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and LC did not have progression to <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> during the 20 and 24 months they have been observed </plain></SENT>
<SENT sid="9" pm="."><plain>Diagnoses other than LC initially were considered in five of the patients </plain></SENT>
<SENT sid="10" pm="."><plain>LC was characterized most often by a dense mixed cellular dermal infiltrate that circumscribed vascular and adnexal structures </plain></SENT>
<SENT sid="11" pm="."><plain>Nine patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (47%) and one with ANLL (8%) had complex chromosomal abnormalities in their bone marrow samples at the time of LC </plain></SENT>
<SENT sid="12" pm="."><plain>This article reports the occurrence of LC in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and suggests that LC is an early manifestation of leukemic transformation in these patients </plain></SENT>
<SENT sid="13" pm="."><plain>These results may be important in identifying high-risk patients for early interventional therapy </plain></SENT>
</text></document>